N/A
N=30
Effects of Mirror Neurons Stimulation on Motor Skill Rehabilitation in Children With Cerebral Palsy
Children With Spastic Diplegia, Between the Ages of 2 to 10 Years · Gross Motor Function Classification System (GMFCS) Level I,II and III
Bottom Line
View on ClinicalTrials.gov: NCT01267929 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Feb 2014
Primary outcome: Primary: The Gross Motor Function Measure (GMFM-66) Score at Entry, the Second and the Sixth Month. — 44.8; 49.4; 54.7; 57.5 Scores on a scale — p=0.34
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- The mirror neurons stimulation based VCD program (Procedure); The conventional physical therapy (Procedure)
- Age
- Pediatric · 2+ yrs
- Sex
- All
- Sponsor
- Thammasat University
- Primary completion
- Aug 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Gross Motor Function Measure (GMFM-66) Score at Entry, the Second and the Sixth Month. |
44.8; 49.4; 54.7; 57.5; 57.8; 63.2 | 0.34 |
Summary
This study aimed to develop Video Compact Disc (VCD) program that applying the concept of imitative learning with mirror neurons stimulation on standard rehabilitation technique in children with cerebral palsy. The author will also examine effectiveness of the program by compare the motor function measured by the gross motor function measure (GMFM-66) between conventional physical therapy and the mirror neurons stimulation based VCD program for six months.
Eligibility Criteria
Inclusion Criteria
- Children with cerebral palsy aged between 2-10 years old
- GMFCS level of one to three
- Able to verbal instruction
- Sitting are performed without assistance
- Standing and walking are performed with adult assistance
- No severe limitation of joint movement
Exclusion Criteria
- The children were received orthopedic intervention or botulinum toxin injection within 6 months
- Seizure
- Other conditions that prevent children from participate in research project
- Severe visual and hearing deficits
Data sourced from ClinicalTrials.gov (NCT01267929). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.